Recent Analysts’ Ratings Updates for Udg Healthcare (UDG)

A number of research firms have changed their ratings and price targets for Udg Healthcare (LON: UDG):

  • 2/7/2018 – Udg Healthcare was upgraded by analysts at Libertas Partners to a “buy” rating. They now have a GBX 884 ($12.21) price target on the stock.
  • 2/7/2018 – Udg Healthcare had its “hold” rating reaffirmed by analysts at N+1 Singer. They now have a GBX 813 ($11.23) price target on the stock.
  • 2/7/2018 – Udg Healthcare was upgraded by analysts at Liberum Capital to a “buy” rating. They now have a GBX 884 ($12.21) price target on the stock.
  • 2/1/2018 – Udg Healthcare had its “add” rating reaffirmed by analysts at Peel Hunt. They now have a GBX 880 ($12.16) price target on the stock.
  • 1/30/2018 – Udg Healthcare had its “reduce” rating reaffirmed by analysts at Numis Securities Ltd. They now have a GBX 765 ($10.57) price target on the stock.
  • 1/30/2018 – Udg Healthcare had its “hold” rating reaffirmed by analysts at Liberum Capital. They now have a GBX 884 ($12.21) price target on the stock.
  • 1/17/2018 – Udg Healthcare had its “hold” rating reaffirmed by analysts at Jefferies Group LLC. They now have a GBX 820 ($11.33) price target on the stock.
  • 12/19/2017 – Udg Healthcare had its “add” rating reaffirmed by analysts at Peel Hunt. They now have a GBX 880 ($12.16) price target on the stock.

Shares of Udg Healthcare PLC (LON UDG) traded up GBX 8.50 ($0.12) during trading on Tuesday, hitting GBX 790 ($10.91). The stock had a trading volume of 853,607 shares, compared to its average volume of 917,000. The firm has a market cap of $1,960.00 and a price-to-earnings ratio of 3,761.90. Udg Healthcare PLC has a fifty-two week low of GBX 662.50 ($9.15) and a fifty-two week high of GBX 963 ($13.30).

The company also recently declared a dividend, which was paid on Monday, February 5th. Stockholders of record on Thursday, January 11th were issued a dividend of $0.10 per share. This represents a dividend yield of 0.84%. This is a positive change from Udg Healthcare’s previous dividend of $0.04. The ex-dividend date of this dividend was Thursday, January 11th.

UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply